ELRON ELECTRONIC INDUSTRIES LTD. (Exact Name of Registrant As Specified in Its Charter and Translation of Registrant’S Name Into English) ______

Total Page:16

File Type:pdf, Size:1020Kb

ELRON ELECTRONIC INDUSTRIES LTD. (Exact Name of Registrant As Specified in Its Charter and Translation of Registrant’S Name Into English) ______ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ______________ FORM 20-F ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 Commission File No. 0-11456 ______________ ELRON ELECTRONIC INDUSTRIES LTD. (Exact name of Registrant as Specified in Its Charter and Translation of Registrant’s Name Into English) ______________ ISRAEL (Jurisdiction of Incorporation or Organization) 3 Azrieli Center, 42nd Floor, Tel-Aviv, Israel 6702301 (Address of Principal Executive Offices) ______________ Yaron Elad, Vice-President & Chief Financial Officer Telephone: (972) 3-607-5555, Facsimile: (972) 3-607-5556 3 Azrieli Center, 42nd Floor, Tel-Aviv, Israel 6702301 (Name, Telephone, E-Mail and/or Facsimile number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act: None Securities registered or to be registered pursuant to Section 12(g) of the Act: Title of each class Ordinary shares, nominal value 0.003 New Israeli Shekels per share Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None ______________ Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report 29,743,767 Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒ If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated filer ☐ Accelerated filer ☒ Non-accelerated filer ☐ Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing: US GAAP ☐ International Financial Reporting Standards as issued by the International Accounting Standards Board ☒ Other ☐ If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. Item 17 ☐ Item 18 ☐ If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ 2 TABLE OF CONTENTS Page No. PART I Item 1. Identity of Directors, Senior Management and Advisers 6 Item 2. Offer Statistics and Expected Timetable 6 Item 3. Key Information 6 Item 4. Information on the Company 28 Item 4A. Unresolved Staff Comments 58 Item 5. Operating and Financial Review and Prospects 59 Item 6. Directors, Senior Management and Employees 87 Item 7. Major Shareholders and Related Party Transactions 109 Item 8. Financial Information 115 Item 9. The Offer and Listing 118 Item 10. Additional Information 119 Item 11. Quantitative and Qualitative Disclosures About Market Risk 146 Item 12. Description of Securities Other than Equity Securities 146 PART II Item 13. Defaults, Dividend Arrearages and Delinquencies 146 Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds 146 Item 15. Controls and Procedures 146 Item 16. [Reserved] 147 Item 16A. Audit Committee Financial Expert 147 Item 16B. Code of Ethics 147 Item 16C. Principal Accountant Fees and Services 148 Item 16D. Exemptions from the Listing Standards for Audit Committees 148 Item 16E. Purchases of Equity Securities by the Issuer and Associate Purchasers 148 Item 16F. Change in Registrant's Certifying Accountant 148 Item 16G. Corporate Governance 148 Item 16H Mine Safety Disclosure 148 PART III Item 17. Financial Statements 149 Item 18. Financial Statements 149 Item 19. Exhibits 149 3 Introduction As used in this annual report on Form 20-F (this "Annual Report"), the terms "we," "us," "our," the "Company" and "Elron" refer to Elron Electronic Industries Ltd. unless otherwise indicated. For the purpose of this Annual Report, the terms "group companies" and "companies in our group" collectively refer to subsidiaries, associates and other companies in which we have direct or indirect holdings through our wholly-owned subsidiaries, Elbit Ltd., or Elbit, and DEP Technology Holdings Ltd., or DEP, including DEP's 50.1% subsidiary, RDC Rafael Development Corporation Ltd., or RDC, and RDC's wholly owned subsidiary, R.D.Seed Ltd., or RDSeed. Our ownership interests in our group companies reflected in this Annual Report represent our beneficial ownership interests in the outstanding shares of these companies as of December 31, 2016 unless otherwise expressly indicated. Our outstanding beneficial ownership interests in the preferred shares of these companies are represented on an as-converted-basis, unless otherwise indicated. Except where expressly otherwise stated herein, our beneficial ownership interests do not take into account dilution due to the exercise of options or other convertible instruments and accordingly are subject to change as a result of the exercise of such options. Furthermore our fully diluted holdings do not take into account options or convertible loans when the amount of shares to be received upon their exercise or conversion, as applicable, is not known in advance. We have also indicated our direct holding and our share in the holding of RDC and RDSeed in a group company where applicable. The references in this Annual Report to the Statement of Financial Position items are as of December 31, 2016 unless otherwise indicated. Please be advised that in order to make our disclosure more consistent with the information disclosed in our previous Annual Report and with our annual report in Hebrew prepared in accordance with Israeli securities laws and regulations, being filed simultaneously with this Annual Report (see also "Item 4.A – History and Development of the Company”), certain information not required by this Annual Report on Form 20-F has been included. Cautionary Note Regarding Forward-Looking Statements This Annual Report includes certain "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and within the meaning of Section 32A of the Israeli Securities Law, 1968. The use of the words "projects," "expects," "may," "plans" or "intends," or words of similar import, identify a statement as "forward-looking." There can be no assurance, however, that actual results will not differ materially from our expectations or projections. Factors that could cause actual results to differ from our expectations or projections include the risks and uncertainties described in this Annual Report under "Item 3 – Key Information – Risk Factors," as well as those discussed elsewhere in this Annual Report and in our other filings with the United States Securities and Exchange Commission (the "SEC"). Any forward-looking statements contained in this Annual Report speak only as of the date of this Annual Report, and we caution investors and potential investors not to place undue reliance on these statements. We undertake no obligation to update or revise any forward-looking statements. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the risk factors in "Item 3 – Key Information – Risk Factors" of this Annual Report. 4 Group Companies Holdings Diagram The following is a diagram of our holdings in our group companies as of December 31, 2016, including the group operating companies held through our subsidiaries, DEP, RDC and RDSeed directly indicating our percentage interests in the outstanding share capital of those of our group companies in which the aggregate amounts invested by us are at least $1 million (reflecting our holding in ordinary shares and preferred shares on an as converted basis and not on a fully diluted basis): 5 (1) In February 2017, our holding in Coramaze increased to approximately 30% following an investment by us and other shareholders. See Item 4.A below for further details. (2) In March 2017, our holding in Nitinotes increased to approximately 24% following the second installment in accordance with the investment agreement. See Item 4.A below for further details. (3) In February 2017, our holding in Alcide decreased to approximately 26% following an investment by us, new investors, and other shareholders. See Item 4.A below for further details. (4) We acquired our holding in AudioBurst Ltd., or AudioBurst, as part of our investment in PlyMedia (2006) Ltd., or Plymedia. (5) In February 2017, RDC's holding in Secdo decreased to approximately 22% following the increase of its funding round by $2 million. See Item 4.A below for further details. (6) In February 2017, RDC's holding in Open Legacy decreased to approximately 40% following the increase of its funding round by approximately $2.3 million.
Recommended publications
  • Celebrating 20 Years of SPECT/CT the Introduction of Hawkeye, the World’S First Hybrid Imaging System
    CLINICAL VALUE HAWKEYE SPECT/CT Celebrating 20 Years of SPECT/CT The introduction of Hawkeye, the world’s first hybrid imaging system Nearly 20 years ago, a pivotal event shaped the future of The unclear medicine nuclear medicine. Once called the “unclear medicine,” nuclear Invented by Hal O. Anger in the mid-1950s, nuclear medicine medicine was forever changed with the introduction of cameras detect gamma radiation to depict metabolic Hawkeye, the world’s first clinical hybrid imaging system. processes within a living body. While gamma cameras helped GE Healthcare (at that time known as GE Medical Systems) revolutionize the field of functional medical imaging, there was introduced Hawkeye, a dual-modality SPECT and CT system, at one key limitation: the lack of anatomical markers in the image. the 1999 Society of Nuclear Medicine (SNM) Annual Meeting, heralding in a new era of “more clear medicine.” “We always understood that we needed anatomical and structural data to provide the best details and a precise answer to the clinical question,” says Ora Israel, MD, Director Emeritus of Nuclear Medicine/PET (retired) at Rambam Healthcare Campus, Haifa, Israel. She recalls using fiducial markers placed on the patient’s body to identify the location of key anatomical areas, such as the chest or abdomen. In some cases, Professor Israel and her colleagues would try to repeat the nuclear medicine study on a CT with the patient in the same position. It was a difficult and time-consuming process that she says never really worked well. “There was a clear purpose to improve the specificity of nuclear medicine by defining the anatomical relationship between isotope imaging and anatomy,” says Martin Sandler, MD, Professor of Radiology and Radiological Sciences and formerly Chairman of the Department of Radiology and Radiological Sciences at Vanderbilt University School of Medicine.
    [Show full text]
  • Elbit Medical Technologies Initiation of Coverage
    Elbit Medical Technologies Initiation of coverage Two promising private assets Pharma & biotech 28 June 2018 Elbit Medical Technologies is an Israel-based healthcare investment company traded on the TASE. It is invested in two private companies: Price* NIS1.12 InSightec is a commercial-stage medical device company marketing a non- Market cap NIS259m invasive thermal tissue ablation therapy in three indications and Gamida *Priced as at 26 June 2018 Cell is a cell and immune therapy company developing a universal bone NIS3.64/US$ marrow transplant (BMT) product for haematological malignancies. Net debt ($m) at 31 December 2017 42.4 Although their recent offerings of NIS182m of convertible notes lengthen Shares in issue 231.4m the cash runway it raises the prospect of dilution in 2022. In addition, the Free float 10.8% parent company Elbit Imaging (~89% owned) has its own challenges. We value Elbit Medical at NIS407m or NIS1.76 per share. Code EMTC Primary exchange TASE Revenue PBT* EPS* DPS P/E Yield Secondary exchange N/A Year end ($m) ($m) ($) ($) (x) (%) 12/15 1.8 (1.1) 0.0 0.0 N/A N/A Share price performance 12/16 0.0 (3.7) 0.0 0.0 N/A N/A 12/17 0.0 (5.2) 0.0 0.0 N/A N/A Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments. InSightec: A non-invasive operating room Elbit Medical currently holds a ~22% (~19% fully diluted) stake in InSightec, a commercial-stage medical device company.
    [Show full text]
  • NASDAQ Stock Market
    Nasdaq Stock Market Friday, December 28, 2018 Name Symbol Close 1st Constitution Bancorp FCCY 19.75 1st Source SRCE 40.25 2U TWOU 48.31 21st Century Fox Cl A FOXA 47.97 21st Century Fox Cl B FOX 47.62 21Vianet Group ADR VNET 8.63 51job ADR JOBS 61.7 111 ADR YI 6.05 360 Finance ADR QFIN 15.74 1347 Property Insurance Holdings PIH 4.05 1-800-FLOWERS.COM Cl A FLWS 11.92 AAON AAON 34.85 Abiomed ABMD 318.17 Acacia Communications ACIA 37.69 Acacia Research - Acacia ACTG 3 Technologies Acadia Healthcare ACHC 25.56 ACADIA Pharmaceuticals ACAD 15.65 Acceleron Pharma XLRN 44.13 Access National ANCX 21.31 Accuray ARAY 3.45 AcelRx Pharmaceuticals ACRX 2.34 Aceto ACET 0.82 Achaogen AKAO 1.31 Achillion Pharmaceuticals ACHN 1.48 AC Immune ACIU 9.78 ACI Worldwide ACIW 27.25 Aclaris Therapeutics ACRS 7.31 ACM Research Cl A ACMR 10.47 Acorda Therapeutics ACOR 14.98 Activision Blizzard ATVI 46.8 Adamas Pharmaceuticals ADMS 8.45 Adaptimmune Therapeutics ADR ADAP 5.15 Addus HomeCare ADUS 67.27 ADDvantage Technologies Group AEY 1.43 Adobe ADBE 223.13 Adtran ADTN 10.82 Aduro Biotech ADRO 2.65 Advanced Emissions Solutions ADES 10.07 Advanced Energy Industries AEIS 42.71 Advanced Micro Devices AMD 17.82 Advaxis ADXS 0.19 Adverum Biotechnologies ADVM 3.2 Aegion AEGN 16.24 Aeglea BioTherapeutics AGLE 7.67 Aemetis AMTX 0.57 Aerie Pharmaceuticals AERI 35.52 AeroVironment AVAV 67.57 Aevi Genomic Medicine GNMX 0.67 Affimed AFMD 3.11 Agile Therapeutics AGRX 0.61 Agilysys AGYS 14.59 Agios Pharmaceuticals AGIO 45.3 AGNC Investment AGNC 17.73 AgroFresh Solutions AGFS 3.85
    [Show full text]
  • Foreign Private Issuers Lists, 1996
    u.s. Securities and Exchange Commission FOREIGN COMPANIES REGISTERED AND REPORTING WITH THE u.S. SECURITIES AND EXCHANGE COMMISSION DECEMBER 31 , 1996 Office of International Corporate Finance Division of Corporation Finance REPORTING FOREIGN ISSUERS AS OF DECEMBER 31, 1996 SUMMARY"INFORMATION REPORTING COUNTRY COMPANIES CANADA 374 UNITED KINGDOM 81 ISRAEL 71 MEXICO 30 NETHERLANDS 29 AUSTRALIA 26 BERMUDA 22 CHILE 22 JAPAN 21 FRANCE 18 ITALY 13 ARGENTINA 12 BRITISH VIRGIN ISLANDS 11 IRELAND 11 SWEDEN 10 INDONESIA 9 GERMANY 8 LUXEMBOURG 8 SPAIN 8 NETHERLANDS ANTILLES 7 NORWAY 7 BAHAMAS 6 SOUTH AFRICA 6 CHINA 5 FINLAND 5 HONG KONG 5 LIBERIA 5 BRAZIL 4 CAYMAN ISLANDS 4 COLOMBIA 4 DENMARK 4 KOREA 4 NEW ZEALAND 4 VENEZUELA 4 PERU 3 PORTUGAL 3 SINGAPORE 3 BELGIUM 2 PANAMA 2 PHILIPPINES 2 BELIZE 1 BOTSWANA 1 GHANA 1 PAPUA NEW Gl.!lNEA 1 RUSSIA 1 SWITZERLAND 1 TAIWAN 1 ZAMBIA 1 TOTAL 881 p MARKET SUMMARY BY COUNTRY NASDAQ NASDAQ COUNTRY NYSE AMEX NMS Small Cap OTC COMBINED ARGENTINA 10 0 1 0 1 12 26 AUSTRALIA 9 0 7 3 7 BAHAMAS 1 0 2 0 3 6 BELGIUM 0 0 2 0 0 2 BELIZE 0 0 1 0 0 1 BERMUDA 9 3 7 1 2 22 BOTSWANA 0 0 0 0 1 1 4 BRAZIL 2 0 1 0 1 BRIT. V.1. 0 0 8 1 2 11 CANADA 61 39 94 57 123 374 CAYMAN ISLANDS 0 2 2 0 0 4 CHILE 19 0 1 0 2 22 CHINA 5 0 0 0 0 5 COLOMBIA 2 0 0 0 2 4 DENMARK 3 0 1 0 0 4 FINLAND 3 '0 0 1 1 5 FRANCE 9 0 6 0 3 18 GERMANY 5 0 1 0 2 8 GHANA 1 0 0 0 0 1 HONG KONG 1 0 0 0 4 5 0 4 9 I INDONESIA 4 0 1 IRELAND 5 0 3 1 2 11 ISRAEL 4 5 45 11 6 71 ITALY 11 0 2 0 0 13 JAPAN 11 0 7 1 2 21 KOREA 3 0 0 0 1 4 LIBERIA 2 2 0 0 1 5 LUXEMBOURG 3 0 5 0 0 8 MEXICO 25 2 0 0 3 30 NETH.
    [Show full text]
  • Alphabetical Listing by Company Name
    FOREIGN COMPANIES REGISTERED AND REPORTING WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION December 31, 2015 Alphabetical Listing by Company Name COMPANY COUNTRY MARKET 21 Vianet Group Inc. Cayman Islands Global Market 37 Capital Inc. Canada OTC 500.com Ltd. Cayman Islands NYSE 51Job, Inc. Cayman Islands Global Market 58.com Inc. Cayman Islands NYSE ABB Ltd. Switzerland NYSE Abbey National Treasury Services plc United Kingdom NYSE - Debt Abengoa S.A. Spain Global Market Abengoa Yield Ltd. United Kingdom Global Market Acasti Pharma Inc. Canada Capital Market Acorn International, Inc. Cayman Islands NYSE Actions Semiconductor Co. Ltd. Cayman Islands Global Market Adaptimmune Ltd. United Kingdom Global Market Adecoagro S.A. Luxembourg NYSE Adira Energy Ltd. Canada OTC Advanced Accelerator Applications SA France Global Market Advanced Semiconductor Engineering, Inc. Taiwan NYSE Advantage Oil & Gas Ltd. Canada NYSE Advantest Corp. Japan NYSE Aegean Marine Petroleum Network Inc. Marshall Islands NYSE AEGON N.V. Netherlands NYSE AerCap Holdings N.V. Netherlands NYSE Aeterna Zentaris Inc. Canada Capital Market Affimed N.V. Netherlands Global Market Agave Silver Corp. Canada OTC Agnico Eagle Mines Ltd. Canada NYSE Agria Corp. Cayman Islands NYSE Agrium Inc. Canada NYSE AirMedia Group Inc. Cayman Islands Global Market Aixtron SE Germany Global Market Alamos Gold Inc. Canada NYSE Alcatel-Lucent France NYSE Alcobra Ltd. Israel Global Market Alexandra Capital Corp. Canada OTC Alexco Resource Corp. Canada NYSE MKT Algae Dynamics Corp. Canada OTC Algonquin Power & Utilities Corp. Canada OTC Alianza Minerals Ltd. Canada OTC Alibaba Group Holding Ltd. Cayman Islands NYSE Allot Communications Ltd. Israel Global Market Almaden Minerals Ltd.
    [Show full text]
  • Renewable Energy – Green and Profitable Is Possible Green Building in Israel Brings Home Renewable Energy
    No. 6 | December 5, 2014 Innovation Industry & Science The State of Israel – Promoting and Securing Innovative Green Energy Solutions Arava Power Company – Eventful Year of New Projects Nation-E – Making Energy Cyber Security Affordable Shikun & Binui Renewable Energy – Green and Profitable Is Possible Green building in Israel brings home renewable energy Green building and renewable energy in Israel Very quietly, without expending too much energy, hundreds of buildings are going up that are in the process of receiving green building certification. The Israeli green building standard No. 5281 validates the building’s energy efficiency. The field of green building in Israel provides opportunities for RE developers to streamline energy efficiency in buildings and turn them into energy producers. Green building and RE are two integrated fields aiming to create buildings that are healthier and more environmentally friendly. Developers, let’s build homes that produce energy themselves. www.sviva.gov.il You’re invited to take part- the future is in green building. Contents 04 Another Year and Still "Almost There…" | By Jon Cohen 08 The New Pioneers 10 Energy Cyber Security Needs to be Affordable... 19 We Seek Energy Projects with Attractive Risk/Reward Profile – Investments that “Make Sense” 24 The German-Israeli Chamber of Commerce on the Latest Trends in Making Municipal Services Greener | By Benjamin Friedländer and Gregor Schlosser * All interviews, except Shikun&Binui or if else mentioned, were conducted by Uri Schlesinger Dear Readers,
    [Show full text]
  • Company Country
    Company Country 1 Teva Pharmaceutical ISR 2 Coca-Cola HBC AG GRC 3 Bank Hapoalim ISR 4 Israel Chemicals ISR 5 Bank Leumi ISR 6 Bezeq ISR 7 Azrieli Group ISR 8 Hellenic Telecommunications Organization S.A. GRC 9 Nice Systems ISR 10 Elbit Systems ISR 11 OPAP GRC 12 Mizrahi Tefahot Bank Ltd. ISR 13 Delek Group ISR 14 Frutarom ISR 15 Osem Investments ISR 16 Israel Discount Bank ISR 17 Israel Corporation ISR 18 Hellenic Petroleum S.A. GRC 19 Gazit Globe (1982) Ltd ISR 20 BANK OF CYPRUS PUBLIC COMPANY LTD CYP 21 Titan Cement Co. S.A. GRC 22 Melisron ISR 23 Alpha Bank S.A. GRC 24 National Bank of Greece S.A. GRC 25 Paz Oil ISR 26 Strauss Group ISR 27 Folli Follie GRC 28 Motor Oil Hellas Corinth Refineries S.A. GRC 29 First Intl Bank of Israel (5) ISR 30 Public Power Corp. S.A. GRC 31 Jumbo S.A. GRC 32 Oil Refineries ISR 33 Alony Hetz Properties & Inv ISR 34 Tower Semiconductor Ltd ISR 35 Migdal Insurance & Financial Holdings Ltd. ISR 36 Grivalia Properties R.E.I.C GRC 37 Harel Investments & Finance ISR 38 Delek Automotive Systems ISR 39 Amot Investments Ltd. ISR 40 Clal Insurance ISR 41 Delta Galil Industries ISR 42 Shikun & Binui Ltd ISR 43 Airport City Ltd ISR 44 Kenon Holdings ISR 45 Athens Water Supply & Sewerage GRC 46 Ezchip Semiconductor ISR 47 Jerusalem Oil Exploration ISR 48 Phoenix Holdings ISR Company Country 49 IDI Insurance Company Ltd ISR 50 Cellcom Israel Ltd. ISR 51 Partner Communications ISR 52 VIOHALCO SA/NV (CB) GRC 53 Mytilineos Holdings S.A.
    [Show full text]
  • Migdal Insurance and Financial Holdings Ltd. and Its Subsidiaries
    Translated from the Hebrew original MIGDAL INSURANCE AND FINANCIAL HOLDINGS LTD. AND ITS SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2009 WorldReginfo - 46d726c5-4d68-401f-9270-2f760ed6a13f MIGDAL INSURANCE AND FINANCIAL HOLDINGS LTD. AND ITS SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2009 Index Page Independent Auditors’ report to the shareholders 2 Consolidated Statements of Financial Position 3 - 4 Consolidated Statements of Income 5 Consolidated Statements of Comprehensive Income 6 Consolidated Statements of Changes in Equity 7-9 Consolidated Statements of Cash Flows 10-13 Notes to the Financial Statements as at December 31, 2009 14-265 Appendix 266 - - - - - - - - - - - - WorldReginfo - 46d726c5-4d68-401f-9270-2f760ed6a13f Kost Forer Gabbay & Kasierer 3 Aminadav St. Somekh Chaikin Tel-Aviv 67067, Israel Tel: 972 (3) 6232777 Fax: 972 (3) 5633526 Independent Auditors' Report www.ey.com/il to the Shareholders of Migdal Insurance and Financial Holdings Ltd. We have audited the accompanying consolidated statements of financial position of MIGDAL INSURANCE AND FINANCIAL HOLDINGS LTD. (hereunder - the Company) as at December 31, 2009 and 2008, and the related consolidated income statements, statements of comprehensive income, statements of changes in equity, and statements of cash flows for each of the three years ended, the last of which ended, December 31, 2009. These financial statements are the responsibility of the Company's Board of Directors and Management. Our responsibility is to express an opinion on these financial statements based on our audits. We did not audit the financial statements of companies treated according to the equity value method the investment in which amounted to NIS 543,777 thousand and NIS 244,709 thousand as at December 31, 2009 and 2008, respectively, and the Group’s share in its profits amounted to NIS 87,388 thousand, NIS 58,630 thousand and NIS 51,323 thousand for each of the three years, the last of which ended December 31,2009.
    [Show full text]
  • ISRAEL Global Center for Breakthrough
    ISRAEL Global Center for Breakthrough www.investinisrael.gov.il Bright Source Dear Reader, Israel is recognized as being Israel’s ability to continuously produce high- at the forefront of high- quality innovative products is fundamental to tech innovation, backed by a its capacity to compete globally and the Israeli highly educated and creative government considers it a high priority to ensure workforce and a sound and support Israel’s future competitiveness. infrastructure. Some of the I am confident that the vitality of the Israeli market world’s largest multinational will continue to position it as a global destination corporations developed their for foreign investment and invite you to take part key breakthroughs in Israel, in our future expansion. and the ongoing influx of new companies serve as a sign of the vibrancy of Israel’s industrial research and development. Israel enjoys the highest percentage in the world Sincerely, of engineers in the workforce and one of the Binyamin (Fouad) Ben Eliezer – highest ratios of university degrees and academic publications per capita. Israel’s finest innovations were developed through the combination of necessity, proven problem solving skills and creativity. Due to the close-knit web of Israeli society, the synergetic nature of Israeli industry Minister of Industry, Trade and Labor allows for cross-sectoral adaptations of technology from the security sector to life sciences, IT and communications. Highly trained graduates of the IDF applied cutting edge defense technology to market-changing civilian applications. 3 Intel Dear Investor, Israeli Innovations Israel has a long track record of An ability to quickly respond to market demands market-creating, profit driving and identify future needs as well as to determine Merging Necessity & Ingenuity Striving for SUCCESS breakthrough innovations and provide solutions to global needs across which have positively impacted different sectors; The technological skill of Israeli life worldwide.
    [Show full text]
  • Geographic Listing by Country of Incorporation
    FOREIGN COMPANIES REGISTERED AND REPORTING WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION December 31, 2010 Geographic Listing by Country of Incorporation COMPANY COUNTRY MARKET Antigua Sinovac Biotech Ltd. Antigua Global Mkt Argentina Alto Palermo S.A. Argentina Global Mkt Banco Macro S.A. Argentina NYSE BBVA Banco Frances S.A. Argentina NYSE Cresud Sacif Argentina Global Mkt Empresa Distribuidora y Comercializadora Norte S.A. - Edenor Argentina NYSE Grupo Financiero Galicia S.A. Argentina Global Mkt IRSA Inversiones y Representacions, S.A. Argentina NYSE MetroGas S.A. Argentina OTC Nortel Inversora S.A. Argentina NYSE Pampa Energia SA Argentina NYSE Petrobras Argentina S.A. Argentina NYSE Telecom Argentina S.A. Argentina NYSE Transportadora de Gas del Sur S.A. Argentina NYSE YPF S.A. Argentina NYSE Australia Allied Gold Ltd. Australia OTC Alumina Ltd. Australia NYSE BHP Billiton Ltd. Australia NYSE Genetic Technologies Ltd. Australia Global Mkt Metal Storm Ltd. Australia OTC Novogen Ltd. Australia Global Mkt Orbital Corp Ltd. Australia OTC Prana Biotechnology Ltd. Australia Cap. Mkt Progen Pharmaceuticals Ltd. Australia OTC Rio Tinto Ltd. Australia OTC Samson Oil & Gas Ltd. Australia NYSE-Amex Sims Metal Management Ltd. Australia NYSE Westpac Banking Corp. Australia NYSE Bahamas Calpetro Tankers (Bahamas I) Ltd. Bahamas OTC - Debt Calpetro Tankers (Bahamas II) Ltd. Bahamas OTC - Debt Calpetro Tankers (Bahamas III) Ltd. Bahamas OTC - Debt Ultrapetrol (Bahamas) Ltd. Bahamas Global Mkt Belgium Anheuser-Busch Inbev SA/NV Belgium NYSE Etablissements Delhaize Freres & Cie - Le Lion Belgium NYSE Page 1 COMPANY COUNTRY MARKET Bermuda AllShips Ltd. Bermuda OTC Alpha and Omega Semiconductor Ltd. Bermuda Global Mkt Asia Pacific Wire & Cable Corp.
    [Show full text]
  • 2/26/2010 Root-Suffix Affected NASDAQ-Listed Symbols.Xlsx Current Symbol Security Name AMSWA American Software, Inc. Class A
    2/26/2010 Root-Suffix Affected NASDAQ-Listed Symbols.xlsx Current Symbol Security Name AMSWA American Software, Inc. Class A Common Stock AMTCP Ameritrans Capital Corporation 9.375% Participating Preferred Stock APAGF Apco Oil and Gas International Inc. Ordinary Shares APCVZ Fresenius Kabi Pharmaceuticals Holding, Inc. Contingent Value Rights ARDNA Arden Group, Inc. Class A Common Stock ARTNA Artesian Resources Corporation Class A Common Stock ASCMA Ascent Media Corporation Series A Common Stock ASRVP AmeriServ Financial Inc. AmeriServ Financial Trust I - 8.45% Beneficial Unsecured Securities, Series A ASTIZ Ascent Solar Technologies, Inc. Class B Warrants ASURD Asure Software, Inc Common Stock AUTCU AutoChina International Limited Unit AUTCW AutoChina International Limited Warrant BANFP BancFirst Corporation - BFC Capital Trust II Cumulative Trust Preferred Securities BELFA Bel Fuse Inc. Class A Common Stock BELFB Bel Fuse Inc. Class B Common Stock BLDRR Builders FirstSource, Inc. transferable subscription rights BNHNA Benihana Inc. Class A Common Stock BPOPM Popular, Inc. Popular Capital Trust II - 6.125% Cumulative Monthly Income Trust Preferred Securities BPOPN Popular, Inc. 6.70% Cumulative Monthly Income Trust Preferred Securities BWINA Baldwin & Lyons, Inc. Class A Common Stock BWINB Baldwin & Lyons, Inc. Class B Common Stock CABLU China Cablecom Holdings, Ltd. Units (British Virgin Islands) CABLW China Cablecom Holdings, Ltd. Warrants 4/10/2010 (British Virgin Islands) CALPW Caliper Life Sciences Inc Warrant CBMXW CombiMatrix Corporation Warrants CCPCN Capital Crossing Preferred Corporation Series D Non-Cumulative Exchangeable Preferred Stock CENTA Central Garden & Pet Company Class A Common Stock Nonvoting CHINA CDC Corporation Class A Common Shares CHOPU China Gerui Advanced Materials Group Limited Units 1 Sh & 2 Wts (Virgin Islands British) CHOPW China Gerui Advanced Materials Group Limited Warrant 03/19/2011 (Virgin Islands British) CHSCP CHS Inc.
    [Show full text]
  • Anglia Ruskin University Faculty of Education
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Anglia Ruskin Research Online Anglia Ruskin University Faculty of Education Corporate Social and Financial Performance: The Case of Companies in Israel Yeshayahu (Shaike) Marom Thesis in partial fulfillment of the Requirements of Anglia Ruskin University For the degree of DOCTOR OF PHILOSOPY Submitted: August 2010 ACKNOWLEDGEMENTS Special thanks to my supervisors: Prof. Vernon Trafford, ARU, Chelmsford, UK: Your wide knowledge and abstract thinking lighted my way into doctorateness thinking. Dr. Andy Armitage, ARU, Chelmsford, UK: Your practical advice helped me through the hard work of Ph.D. thesis. To the Anglia Ruskin University staff that was very supportive throughout my research: Dr. Gill Robinson, ARU, UK Professor. Gina Wisker, ARU, UK To the Israeli Ph.D. coordinators: Mr. Dani Shenkar Mr. Avishai Tal i TABLE OF CONTENTS ABSTRACT ............................................................................................................ viii CHAPTER 1 INTRODUCTION................................................................................1 CORPORATE SOCIAL RESPONSIBILITY .........................................................................1 CSR IMPACT ON FINANCIAL PERFORMANCE ...............................................................2 PREVIOUS EMPIRICAL RESEARCH ................................................................................5 CONTEXT SETTING ......................................................................................................5
    [Show full text]